AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.
Lire l’article complet sur le site source
Bloomberg — Markets (EN)